2023-09-27 16:30:00
Cancer Network Foundation, in collaboration with hematology specialists and the MPN Patients Club, is organizing an online discussion to raise awareness about blood cancer during Blood Cancer Awareness Month. The event, titled “Be aware of chronic abnormal bone marrow production of blood cells. Blood cancers, MPNs, and MDS,” will take place on September 9th and aims to provide knowledge about the disease and its treatment guidelines.
Asst. Prof. Dr. Noppadol Sirithanaratanakul, the chairman of the MPN & MDS Working group of hematology experts, highlighted the increasing prevalence of blood cancer among individuals aged 60 and above in Thailand. This has prompted the organization of the seminar to educate patients, caregivers, and the public about the disease and provide them with practical knowledge.
Ms. Sirinthip Khattiyakarn, President of the Cancer Network Foundation, emphasized the importance of spreading knowledge about cancer and blood diseases to increase awareness and understanding among the general population. She encouraged people to listen to previous episodes on the Foundation’s Facebook page and visit their website for more information.
Assoc. Prof. Dr. Nonglak Kanitsap discussed the different types of blood cancers caused by chronic abnormal bone marrow production. The most common types include thick blood disease, high platelet disease, and bone marrow fibrosis. Patients may experience symptoms such as fatigue, dizziness, headaches, skin symptoms, abdominal distension, and fever.
In the initial diagnosis of MPNs and MDS, doctors typically take patients’ medical history, perform a physical examination to check for an enlarged spleen, and conduct a complete blood count (CBC) to identify abnormalities in blood cell components. Additional diagnostic tests, such as bone marrow aspiration, may be required.
Treatment for MPNs involves antiplatelet drugs, chemotherapy, drugs that target JAK2 inhibitors, and medications to reduce blood cell production. In severe cases, bone marrow transplants may be necessary. Regular monitoring of symptoms through blood tests is crucial to assess progress and adjust treatment accordingly.
Assoc. Prof. Dr. Chantana Phonprasert provided insights into MDS, a disease characterized by abnormalities in stem cells in the bone marrow. Patients may experience symptoms such as anemia, easy bleeding, and increased susceptibility to infections. The causes of MDS are not fully understood but are believed to be associated with exposure to carcinogenic chemicals, heavy metals, radiation, and certain medications.
Diagnosing MDS involves taking a patient’s history, conducting blood tests, liver and kidney function tests, bone marrow examination, and testing for chromosomal abnormalities and gene mutations. Treatment options include injections to stimulate red blood cells, hormone therapy, platelet-stimulating drugs, and white blood cell-stimulating drugs. Bone marrow transplantation is recommended for high-risk patients below the age of 65.
Dr. Sunisa Kongkiatkamon from Chulalongkorn Hospital, Thai Red Cross Society, emphasized the importance of patients actively monitoring their symptoms and treatment results. Patients can utilize assessment forms to evaluate symptoms and observe any changes before and after treatment. Regular communication with healthcare providers is essential to address any concerns and adjust treatment plans accordingly.
In conclusion, the online discussion organized by the Cancer Network Foundation, in collaboration with hematology specialists and the MPN Patients Club, aims to improve awareness and understanding of blood cancer among the Thai population. The event will provide valuable knowledge about the disease, its treatment guidelines, and practical tips for managing symptoms and maintaining a good quality of life.]
#Cancer #Network #Foundation #joins #hands #partners #Inviting #awareness #blood #cancer #month